MedPath

ong-term safety trial - Non-blinded safety verification test using a dose of the test food "FGPPY30" five times higher than that intended for healthy individuals

Not Applicable
Conditions
Healthy person
Registration Number
JPRN-UMIN000020608
Lead Sponsor
Medical Fusion Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

The following exclusion criteria apply to subjects. -Use of any drugs from -7 day to -1 day before dosing. -A person who have used the steroid drug within the past three months of consent acquisition date. -A person with diseases of the digestive tract, liver, kidney, heart, and circulatory system that might affect test food absorption, distribution, metabolism, and excretion. -A person with a lengthy surgical history, including gastrointestinal suture surgery, or intestinal resection. However, polypectomy and appendectomy will not exclude a patient. -A person with a history of cerebrovascular disease (asymptomatic lacunar infarction is excluded). -A person with tattoo. -A person with hypersensitivity or idiosyncrasy, such as food allergies. -A person with alcohol or drug dependency. -A person who has participated in other clinical trials within 84 days of giving informed consent. -A person who has donated 400 ml of blood within 84 days, 200 ml of blood within 28 days, or a blood component (plasma or platelets) within 14 days of giving informed consent. -The person who hopes for pregnancy or the person who can't prevent conception during the clinical study. -Nursing or pregnant woman. -A person whose diagnosis requires treatment of mental illness by a clinical investigator. -A person who are engaged in night duty. -A person who is unable to comply with administrative matters during the clinical study. -A person who are determined ineligible by the clinical investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Confirmation of adverse events
Secondary Outcome Measures
NameTimeMethod
-Physical signs, physical symptom, primary disease, complications, anamnesis, history of present illness -Concomitant medications, adjunctive therapy -Body temperature -Blood pressure/pulse -Height, weight,Body mass index(BMI) -12-lead electrocardiogram -General hematology tests -Blood biochemistry tests -Antioxidants, oxidative stress and adiponectin -Urinalysis -The fecal situation (fecal frequency, fecal volume , fecal property) -Meal recording
© Copyright 2025. All Rights Reserved by MedPath